Literature DB >> 29128513

Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells.

Eunji Im1, Changhwan Yeo1, Hyo-Jeong Lee2, Eun-Ok Lee3.   

Abstract

AIMS: Dihydroartemisinin (DHA) is a semi-synthetic derivative of artemisinin, well known for a safe and effective first-line antimalarial agent. This study investigated whether and how DHA induces apoptosis focusing on the specificity protein 1 (Sp1) pathway in hepatocellular carcinoma (HCC) SK-Hep-1 cells. MAIN
METHODS: The cell viability was evaluated by MTT assay. Cell cycle analysis was performed after PI staining by flow cytometry system. Apoptosis was confirmed by DAPI staining and by detecting cytoplasmic histone-associated-DNA-fragments using a cell death detection ELISAPLUS kit. The expression of proteins involved in apoptosis was evaluated by Western blot. The nuclear localization of Sp1 was evaluated by immunofluorescence assay. KEY
FINDINGS: DHA exerted potent cytotoxicity against HCC SK-Hep-1 cells compared with normal hepatocyte AML12 cells. The sub-G1 DNA content and apoptosis index were increased by DHA, which was accompanied by nuclei condensation and fragmentation. DHA activated caspase 3, caspase 8, and caspase 9 and cleaved poly (ADP-ribose) polymerase (PARP). DHA-induced apoptotic cell death, activation of caspases and cleavage of PARP were dramatically inhibited by pan caspase inhibitor Z-VAD-FMK. DHA down-regulated protein expression and nuclear localization of Sp1, which in turn decreased Sp1 downstream target protein, X-linked inhibitor of apoptosis. Decreased Sp1 protein expression by DHA was restored by proteasome inhibitor MG132. DHA led to a down-regulation of phospho-ERK, -p38 and -JNK without affecting their total forms. SIGNIFICANCE: These results demonstrate that DHA induces caspase-dependent apoptosis in HCC SK-Hep-1 cells by proteasome-dependent degradation of Sp1, which is involved in mitogen-activate protein kinase pathway.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Caspase; Dihydroartemisinin; SK-Hep-1 cells; Sp1

Mesh:

Substances:

Year:  2017        PMID: 29128513     DOI: 10.1016/j.lfs.2017.11.008

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells.

Authors:  Qi Rao; Ruochan Li; He Yu; Lei Xiang; Bin He; Fenghua Wu; Gang Zhao
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

Review 2.  Potential applications of artemisinins in ocular diseases.

Authors:  Bing-Wen Lu; Li-Ke Xie
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

Review 3.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

4.  Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition.

Authors:  Renxin Yi; Handong Wang; Chulei Deng; Xinyue Wang; Lei Yao; Wenhao Niu; Maoxing Fei; Wangdui Zhaba
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

5.  Iron Promotes Dihydroartemisinin Cytotoxicity via ROS Production and Blockade of Autophagic Flux via Lysosomal Damage in Osteosarcoma.

Authors:  Ying Shen; Bin Zhang; Yanwei Su; Shaikh Atik Badshah; Xiaofei Wang; Xin Li; Yanru Xue; Li Xie; Zhe Wang; Zhouqi Yang; Ge Zhang; Peng Shang
Journal:  Front Pharmacol       Date:  2020-05-05       Impact factor: 5.810

6.  Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.

Authors:  Changhwan Yeo; Deok-Soo Han; Hyo-Jeong Lee; Eun-Ok Lee
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

7.  Dihydroartemisinin inhibits HepG2.2.15 proliferation by inducing cellular senescence and autophagy.

Authors:  Jiang Zou; Qiang Ma; Ru Sun; Jiajing Cai; Hebin Liao; Lei Xu; Jingruo Xia; Guangcheng Huang; Lihua Yao; Yan Cai; Xiaowu Zhong; Xiaolan Guo
Journal:  BMB Rep       Date:  2019-08       Impact factor: 5.041

8.  Dihydroartemisinin inhibits multiplication of Brucella suis vaccine strain 2 in murine microglia BV2 cells via stimulation of caspase‑dependent apoptosis.

Authors:  Juan Yang; Haining Li; Zhao Wang; Liming Yu; Qiang Liu; Xiaoyan Niu; Ting Xu; Zhenhai Wang
Journal:  Mol Med Rep       Date:  2019-09-11       Impact factor: 2.952

9.  Dihydroartemisinin Sensitizes Mutant p53 (R248Q)-Expressing Hepatocellular Carcinoma Cells to Doxorubicin by Inhibiting P-gp Expression.

Authors:  Yue Yang; Jianxin He; Jing Chen; Li Lin; Yongqi Liu; Cunmin Zhou; Yun Su; Hulai Wei
Journal:  Biomed Res Int       Date:  2019-12-31       Impact factor: 3.411

Review 10.  Dihydroartemisinin: A Potential Natural Anticancer Drug.

Authors:  Xiaoshuo Dai; Xiaoyan Zhang; Wei Chen; Yihuan Chen; Qiushuang Zhang; Saijun Mo; Jing Lu
Journal:  Int J Biol Sci       Date:  2021-01-16       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.